Iron Overdose
Critical Alerts
- Iron poisoning can be rapidly fatal - especially in children
- Four phases of toxicity - watch for deceptive "quiet phase"
- Abdominal X-ray may show radiopaque tablets
- Deferoxamine is the antidote - start early if severe
- GI bleeding and acidosis are hallmarks of severe toxicity
Key Diagnostics
- Serum iron level (peak at 4-6 hours)
- TIBC (total iron binding capacity) - less useful acutely
- ABG/VBG (metabolic acidosis)
- CBC, coagulation panel
- BMP (glucose, renal function)
- Abdominal X-ray (radiopaque pills)
Emergency Treatments
- GI decontamination: Whole bowel irrigation if intact tablets on X-ray
- Deferoxamine: 15 mg/kg/hr IV for severe toxicity
- IV fluids: Aggressive resuscitation for hypovolemia
- Bicarbonate: For severe metabolic acidosis
- Avoid charcoal: Does not bind iron
Iron overdose is a potentially life-threatening toxicity resulting from ingestion of elemental iron, typically from iron supplement tablets. It is particularly dangerous in children due to the availability of attractive-looking iron supplements. The toxic effects are mediated by free iron's corrosive action on the GI tract and cellular toxicity from oxidative damage.
Iron Content of Common Preparations
| Preparation | Elemental Iron Content |
|---|---|
| Ferrous sulfate 325mg | 65mg (20%) |
| Ferrous gluconate 325mg | 38mg (12%) |
| Ferrous fumarate 325mg | 106mg (33%) |
| Prenatal vitamins | 30-65mg |
| Children's multivitamin | 10-18mg |
Toxicity Thresholds
| Dose (Elemental Iron) | Expected Severity |
|---|---|
| <20 mg/kg | Non-toxic to mild GI symptoms |
| 20-60 mg/kg | Moderate toxicity |
| >0 mg/kg | Severe toxicity, potentially fatal |
| >50 mg/kg | Usually fatal without treatment |
Epidemiology
- Peak incidence: Children ages 1-3 years (accidental ingestion)
- Leading cause: Pediatric poisoning death from pharmaceuticals (historically)
- Adults: Often intentional overdose
- Improved safety: Unit-dose packaging has reduced pediatric deaths
Mechanism of Toxicity
Phase 1: Direct GI Toxicity (0-6 hours)
- Iron is directly corrosive to GI mucosa
- Mucosal necrosis and hemorrhage
- Third-spacing of fluids → hypovolemia
- May cause GI perforation in severe cases
Phase 2: Systemic Toxicity
- Absorbed iron exceeds binding capacity (transferrin)
- Free iron catalyzes free radical formation (Fenton reaction)
- Oxidative damage to mitochondria
- Cellular dysfunction and death
Target Organs
| Organ | Effect |
|---|---|
| Liver | Periportal necrosis, hepatic failure |
| Heart | Cardiomyopathy, arrhythmias |
| Kidney | Acute tubular necrosis |
| Vasculature | Vasodilation, capillary leak |
Metabolic Effects
Anion Gap Metabolic Acidosis
- Lactic acid from tissue hypoperfusion
- Inhibition of mitochondrial function
- Release of hydrogen ions from iron-hydroxide complexes
- Serves as marker of severity
Four Phases of Iron Toxicity
Phase 1: GI Phase (0-6 hours)
| Symptom | Severity Correlation |
|---|---|
| Nausea, vomiting | Common, may be bloody |
| Abdominal pain | Cramping, diffuse |
| Diarrhea | Often bloody |
| Hematemesis | Indicates severe mucosal injury |
Phase 2: Latent Phase (6-24 hours)
Phase 3: Systemic Toxicity Phase (12-48 hours)
| Finding | Mechanism |
|---|---|
| Shock | Hypovolemia, vasodilation, cardiac toxicity |
| Metabolic acidosis | Lactic acid, cellular dysfunction |
| Coagulopathy | Hepatic failure, DIC |
| Hepatic failure | Direct hepatotoxicity |
| Hypoglycemia | Hepatic dysfunction |
| Lethargy/coma | Shock, hepatic encephalopathy |
Phase 4: Late Effects (2-6 weeks)
Clinical Severity Grading
| Grade | Features |
|---|---|
| Asymptomatic | No symptoms, low level |
| Mild | GI symptoms only, no acidosis |
| Moderate | Significant GI symptoms, mild acidosis |
| Severe | Shock, altered mental status, coagulopathy, hepatotoxicity |
Critical Findings
| Red Flag | Concern | Action |
|---|---|---|
| Serum iron >00 mcg/dL | Severe toxicity | Deferoxamine |
| Metabolic acidosis | Cellular toxicity | ICU, deferoxamine |
| Altered mental status | Shock or hepatic failure | ICU, aggressive resuscitation |
| Hypotension | Hypovolemia, cardiac toxicity | Fluid resuscitation, vasopressors |
| Coagulopathy | Hepatic failure | FFP, ICU admission |
| GI bleeding | Severe mucosal injury | Transfusion, consider endoscopy |
| Glucose <60 mg/dL | Hepatic failure | Dextrose |
Prognostic Indicators
Poor Prognosis
- Serum iron >1000 mcg/dL
- pH <7.1
- Shock unresponsive to fluids
- Hepatic failure (elevated INR, transaminases)
- Coma
Other Toxic Ingestions
| Toxin | Features |
|---|---|
| Caustic ingestion | Similar GI injury, no systemic iron effects |
| Theophylline | GI symptoms, acidosis, seizures |
| Salicylates | Acidosis, tinnitus, mixed acid-base |
| Acetaminophen | Hepatotoxicity but delayed 24-72h |
| Heavy metals (arsenic, lead) | GI symptoms, specific levels |
Other Causes of GI Bleeding with Shock
- Upper GI bleed (ulcer, varices)
- Lower GI bleed
- Ischemic bowel
- GI perforation
Initial Assessment
Key History
- Exact product ingested
- Number of pills taken
- Time of ingestion
- Intentional vs accidental
- Co-ingestants
Calculate Elemental Iron Dose
Elemental iron (mg) = Number of tablets × Elemental iron per tablet
Dose (mg/kg) = Total elemental iron ÷ Patient weight (kg)
Laboratory Studies
| Test | Purpose | Critical Values |
|---|---|---|
| Serum iron | Diagnosis and severity | >00 mcg/dL = severe |
| TIBC | Binding capacity | Less useful acutely |
| ABG/VBG | Acidosis | pH <7.35 concerning |
| Glucose | Hepatic function | Low = hepatic failure |
| CBC | Anemia from bleeding | |
| Coagulation | Hepatic function | PT/INR elevated |
| LFTs | Hepatotoxicity | May rise at 12-24h |
| Lactate | Tissue perfusion | Elevated = severe |
Serum Iron Interpretation
| Level (mcg/dL) | Interpretation |
|---|---|
| <300 | Unlikely significant toxicity |
| 300-500 | Moderate toxicity possible |
| 500-1000 | Severe toxicity likely |
| >000 | Life-threatening |
Important Notes:
- Peak level at 4-6 hours post-ingestion
- Level drawn <4 hours may underestimate severity
- Enteric-coated preparations delay absorption
- Level AND clinical status both matter
Imaging
Abdominal X-ray
- Iron tablets are radiopaque
- Useful to confirm ingestion
- Guide need for whole bowel irrigation
- May show pill fragments, bezoar
- Normal X-ray does not exclude significant ingestion (liquid iron, dissolved tablets)
GI Decontamination
Activated Charcoal
- Does NOT bind iron effectively
- Not recommended for isolated iron ingestion
Whole Bowel Irrigation (WBI)
Indication: Significant ingestion with visible pills on X-ray
Solution: Polyethylene glycol electrolyte solution (GoLYTELY)
Rate:
- Adults: 1.5-2 L/hour via NG
- Children: 25-40 mL/kg/hour
Duration: Until rectal effluent clear and no pills on repeat X-ray
Contraindications: Ileus, obstruction, GI perforation, unprotected airway
Gastric Lavage
- Generally not recommended (pills too large)
- May be considered very early (<1 hour) if life-threatening ingestion
Deferoxamine (Antidote)
Mechanism
- Chelates free iron to form ferrioxamine
- Water-soluble complex excreted in urine (vin rosé color)
Indications
- Serum iron >500 mcg/dL
- Severe clinical toxicity (shock, altered mental status, metabolic acidosis)
- Significant ingestion with any systemic symptoms
Dosing
IV Infusion (preferred):
- Initial: 15 mg/kg/hour
- Maximum: 35 mg/kg/hour for life-threatening toxicity
- Daily max: 6-8 g in 24 hours (higher doses associated with ARDS)
Duration: Until clinical improvement AND serum iron <300 mcg/dL AND urine no longer vin rosé colored
Adverse Effects
- Hypotension (if infused too rapidly)
- ARDS with prolonged high-dose therapy (>24 hours)
- Allergic reactions
- Vin rosé urine (expected)
Monitoring During Deferoxamine
- Serial serum iron levels
- ABG/VBG for acidosis
- Urine color
- Blood pressure
Supportive Care
Fluid Resuscitation
- Aggressive crystalloid resuscitation
- Blood products for bleeding (pRBCs, FFP)
- Address third-spacing losses
Acidosis Management
- Sodium bicarbonate for severe acidosis (pH <7.1)
- Correcting perfusion is priority
Coagulopathy
- Fresh frozen plasma
- Vitamin K (hepatic synthetic dysfunction)
Glucose
- Monitor closely
- D50 for hypoglycemia (hepatic failure marker)
Special Circumstances
Bezoar
- Iron concretion in GI tract
- May require endoscopic removal
- Gastric lavage with bicarbonate solution (debated)
- Surgical removal rarely needed
Pregnancy
- Deferoxamine is Category C
- Use if maternal life at risk
- Iron toxicity risk outweighs deferoxamine risk
ICU Admission Criteria
- Serum iron >500 mcg/dL
- Any systemic symptoms (shock, altered mental status)
- Metabolic acidosis
- Coagulopathy or hepatotoxicity
- Need for deferoxamine infusion
- Significant GI bleeding
Observation Unit/Ward
- Serum iron 300-500 mcg/dL with mild symptoms
- Asymptomatic with borderline levels
- Post-decontamination observation
Discharge Criteria (Low-Risk Ingestions)
- Ingestion <20 mg/kg elemental iron
- Asymptomatic at 6 hours
- Serum iron <300 mcg/dL
- Normal acid-base status
- Psychiatric evaluation if intentional (before discharge)
Follow-up Considerations
| Timeframe | Concern |
|---|---|
| 2-6 weeks | GI stricture development |
| If GI symptoms persist | Upper/lower GI evaluation |
| Hepatic injury | Follow LFTs to resolution |
Understanding Iron Poisoning
- Iron supplements can be very dangerous if too much is taken
- Symptoms may appear to improve then worsen significantly
- Treatment in hospital is essential for significant ingestions
Prevention (for Caregivers)
Child Safety
- Store iron supplements out of reach of children
- Use child-resistant containers
- Supervise medication administration
- Teach children that pills are not candy
Signs of Worsening
Return immediately if:
- Vomiting blood
- Bloody diarrhea
- Increasing abdominal pain
- Confusion or drowsiness
- Fainting or dizziness
Pediatric Patients
- More common accidental ingestion
- Lower toxic threshold (lower weight)
- Often more severe outcomes historically
- Calculate dose carefully in mg/kg
Pregnancy
- Iron supplements commonly prescribed
- Deferoxamine crosses placenta but is life-saving
- Treat maternal toxicity aggressively
- Fetal outcomes dependent on maternal outcomes
Enteric-Coated Preparations
- Delayed absorption (peak may be 8-12 hours)
- May not show on X-ray if dissolved
- WBI particularly important
- Multiple serum iron levels recommended
Chronic Iron Overload States
- Hemochromatosis, transfusion-dependent patients
- Already have elevated iron stores
- May be more susceptible to acute toxicity
Performance Indicators
| Metric | Target |
|---|---|
| Serum iron level ordered | 100% |
| Abdominal X-ray if ingestion suspected | >0% |
| Time to deferoxamine if indicated | <2 hours |
| Poison control contacted | 100% |
| Psychiatric evaluation (intentional) | 100% |
Documentation Requirements
- Product and amount ingested
- Elemental iron dose calculated (mg/kg)
- Time of ingestion
- Serial serum iron levels
- Acid-base status
- Deferoxamine administration details
- Response to treatment
- Disposition rationale
Diagnostic Pearls
- Calculate elemental iron dose - determines expected severity
- "Quiet phase" is dangerous - don't be falsely reassured
- Peak iron level at 4-6 hours - draw level appropriately
- X-ray may show pills - helpful for WBI decision
- Acidosis correlates with severity - check ABG
Treatment Pearls
- Charcoal does NOT work for iron - don't use it
- Deferoxamine for severe toxicity - start early
- WBI for visible pills on X-ray
- Watch for hypotension with deferoxamine - infuse slowly
- Vin rosé urine confirms deferoxamine is working
Disposition Pearls
- Observe 6 hours if any GI symptoms
- ICU for any systemic symptoms or high iron level
- Psychiatric evaluation for intentional overdose
- Warn about late strictures (2-6 weeks)
- Poison control is helpful - call them
- Manoguerra AS, et al. Iron ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2005;43(6):553-570.
- Baranwal AK, Singhi SC. Acute iron poisoning: management guidelines. Indian Pediatr. 2003;40(6):534-540.
- Tenenbein M. Hepatotoxicity in acute iron poisoning. J Toxicol Clin Toxicol. 2001;39(7):721-726.
- Mills KC, Curry SC. Acute iron poisoning. Emerg Med Clin North Am. 1994;12(2):397-413.
- Anderson AC. Iron Poisoning. In: Ford MD, et al., eds. Clinical Toxicology. Elsevier; 2001.
- Perrone J. Iron. In: Hoffman RS, et al., eds. Goldfrank's Toxicologic Emergencies. 11th ed. McGraw-Hill; 2019.
| Version | Date | Changes |
|---|---|---|
| 1.0 | 2025-01-15 | Initial comprehensive version with 14-section template |